Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 260))

Abstract

In humans, L-carnitine (L- (-) -3-hydroxy-4-trimethylaminobutyrate, molecular weight 62 daltons) is synthesized in the liver, kidney and brain from the two essential amino acids lysine and methionine mediated by a multi-enzyme system1. Four co-factors — vitamin C, niacin, vitamin B6, and iron — are required by the various enzymes2 , 3 . The rare amino acid N-6-trimethyllysine (TML) is formed by posttranslational methylation of lysine residues with S-adenosylmethionine4. Once released by proteolytic action, it may serve as a precursor for the endogenous biosynthesis of carnitine5 . TML is converted to L-carnitine via four enzymatic steps (hydroxylation, aldol cleavage, oxidation and a second hydroxylation).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rebouche, C.J.: Sites and regulation of carnitine biosynthesis in mammals. Fed. Proc. 41:2848 (1982).

    PubMed  CAS  Google Scholar 

  2. Frenkel, R.A., and McGarry, J.D.: Carnitine biosynthesis, metabolism, and function. Academic Press, New York (1980).

    Google Scholar 

  3. Bremer, J.: Carnitine-metabolism and functions. Physiol. Rev. 63:1420 (1983).

    PubMed  CAS  Google Scholar 

  4. Paik, W.K., Kim, S.: Protein methylation: chemical, enzymological, and biological significance. Advanc. Enzvmol. 42:227 (1975).

    CAS  Google Scholar 

  5. LaBadie, J., Dunn, W.A., and Aronson, N.N.: Hepatic synthesis of carnitine from protein-bound trimethyllysine. Lysosomal digestion of methyl-lysine-labeled asialo-fetuin. Biochem. J. 160:85 (1976).

    PubMed  CAS  Google Scholar 

  6. Fritz, J.B.: Carnitine and its role in fatty acid metabolism. Adv. Lipid Res. 1:285 (1963).

    PubMed  CAS  Google Scholar 

  7. McGarry, J.D.: New perspectives in the regulation of ketogenesis. Diabetes 28:517 (1979).

    PubMed  CAS  Google Scholar 

  8. Borum, P.R.: Carnitine function. In: “Clinical Aspects of Human Carnitine Deficiency”, Borum, P.R., ed., Pergamon Press, New York (1986).

    Google Scholar 

  9. Guarnieri, G., Toigo, G., Crapesi, L., Situlin, R., Del Bianco, M.A., Corsi, M., LoGreco, P., Paviotti, G., Mioni, G., and Campanacci, L.: Carnitine metabolism in chronic renal failure. Kidney Int. 32 (suppl. 22):116 (1987) .

    Google Scholar 

  10. Bieber, L.L., and Lysiak, W.: Characteristics and functions of short-chain and medium-chain carnitine acyltransferases. In: “Clinical Aspects of Human Carnitine Deficiency”, Borum, P.R., ed., Pergamon Press, New York (1986).

    Google Scholar 

  11. Böhmer, T., Bergrem, H., and Eiklid, K.: Carnitine deficiency induced during intermittend haemodialysis for renal failure. Lancet i:126 (1978).

    Article  Google Scholar 

  12. Corsi, M. : Secondary carnitine deficiency in renal dialysis. In: “Clinical Aspects of Human Carnitine Deficiency”, Borum, P.R., ed., Plenum Press, New York (1986) .

    Google Scholar 

  13. Kohse, K.P., Graser, T.A., Rössle, C., Franz, H.E., and Fürst, P.: Effect of hemodialysis on plasma-free trimethyllysine. In: “Immune and Metabolic Aspects of Therapeutic Blood Purification Systems”. Proc. Int. Symp. Trondheim, Karger Basel (1986) .

    Google Scholar 

  14. Penn, D., and Schmidt-Sommerfeld, E.: Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis. Metabolism 32:806 (1983).

    Article  PubMed  CAS  Google Scholar 

  15. Wanner, C., Förstner-Wanner, S., Schaeffer, G., Schollmeyer, P., and Hörl, W.H.: Serum-free carnitine, carnitine esters and lipids in patients on peritoneal and hemodialysis. Am. J. Nephrol. 6:206 (1986).

    Article  PubMed  CAS  Google Scholar 

  16. Rössle, C., Kohse, K.P., Kapp, W. , Franz, H.E., Glöggler, A., Bergström, J., and Fürst, P.: Disturbed carnitine metabolism in hemodialysis patients. Clin. Nutr. 5 (suppl.1):136 (1986).

    Google Scholar 

  17. Wanner, C., Förstner-Wanner, S., Rössle, C., Kohse, K.P., Fürst, P., Schollmeyer, P., and Hörl, W.H.: Carnitine metabolism in patients with chronic renal failure: effects of L-carnitine supplementation. Kidney Int. 32 (suppl. 22):132 (1987).

    Google Scholar 

  18. Guarnieri, G.F., Carretta, R., Toigo, G., and Campanacci, L.: Acetate intolerance in chronic uremic patients. Nephron 24:212 (1979).

    Article  PubMed  CAS  Google Scholar 

  19. Ricanati, E.S., Tserng, K.Y., and Hoppel, C.L.: Abnormal fatty acid utilization during prolonged fasting in chronic uremia. Kidney Int. 32 (suppl. 22):145 (1987).

    Google Scholar 

  20. Vinay, P., Cardoso, M., Tejedor, A., Prud’homme, M., Levelille, M., Vinet, B., Courteau, M., Gongoux, A., Rengel, M., Capierre, L., and Piette, Y.: Acetate metabolism during hemodialysis: metabolic considerations. Am. J. Nephrol. 7:337 (1987).

    Article  PubMed  CAS  Google Scholar 

  21. Engel, A.G., and Rebouche, C.J.: Carnitine metabolism and inborn errors. J. Inher. Metab. Dis. 7 (suppl. 1):38 (1984).

    Article  PubMed  CAS  Google Scholar 

  22. Bertoli, M., Battistella, P.A., Vergani, L. , Naso, A., Gasparotto, M.L. , Romagnoli, G.F., and Angelini, C.: Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Am. J. Clin. Nutr. 34:1496 (1981).

    PubMed  CAS  Google Scholar 

  23. Salvica, V., Bellinghieri, G., DiStefano, C., Corvaja, E., Consolo, F., Corsi, M., Maccari, F., Spagnoli, L.G., Villaschi, S., and Palmieri, G.: Plasma and muscle carnitine levels in hemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 35:232 (1983).

    Article  Google Scholar 

  24. Moorthy, A.V., Rosenblum, M., Rajaram, R., and Shug, A.L.: A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am. J. Nephrol. 3:205 (1983).

    Article  PubMed  CAS  Google Scholar 

  25. Mingardi, G., Bizzi, A., Cini, M., Licine, R., Mecca, G., and Garattini, S.: Carnitine balance in hemodialyzed patients. Clin. Nephrol. 13:269 (1980).

    PubMed  CAS  Google Scholar 

  26. Fagher, B., Cederblad, G., Monti, M., Osson, L., Rasmussen, B., and Thysell, H.: Carnitine and left ventricular function in hemodialysis patients. Scand. J. Clin. Lab. Invest. 45:193 (1985) .

    Article  PubMed  CAS  Google Scholar 

  27. Bazzi, C., DiDonato, S., Castaglione, A. , Bazzi, C., DiDonato, S., Castaglione, A., Corsi, M., and D’Amico, G.: Carnitine metabolism in short- and long-term maintenance hemodialysis. In: Clinical Aspects of Human Carnitine Deficiency, Borum, P.R., ed., Pergamon Press, New York (1986) .

    Google Scholar 

  28. Chan, M.K., Varghese, Z., and Moorhead, J.F.: Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int. 19:625 (1981).

    Article  PubMed  CAS  Google Scholar 

  29. Wanner, C., and Hörl, W.H.: Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects. Nephron 50:89 (1988).

    Article  PubMed  CAS  Google Scholar 

  30. Gerondaes, P., Alberti, K., and Agius, L.: Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Biochem. J. 253:161 (1988).

    PubMed  CAS  Google Scholar 

  31. Vacha, G.M., Giorcelli, G., Siliprandi, N., and Corsi, M.: Favourable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoproteincholesterol. Am. J. Clin. Nutr. 38:532 (1983).

    PubMed  CAS  Google Scholar 

  32. Zilleruelo, G., Novak, M., Freundlich, M., Goldberg, R. , Abitol, C., and Strauss, J.: L-carnitine supplementation ameliorates hyperlipidemia in children on hemodialysis. In: “Clinical Aspects of Human Carnitine Deficiency”, Borum, P.R., ed., Pergamon Press, New York (1986).

    Google Scholar 

  33. Nilsson-Ehle, P., Cederblad, G., Fagher, B., Monti, M., and Thysell, H.: Plasma lipoproteins, liver function and glucose metabolism in hemodialysis patients: lack of effect of L-carnitine supplementation. Scand. J. Clin. Lab. Invest. 45:179 (1985).

    Article  PubMed  CAS  Google Scholar 

  34. Ahmad, S., Golper, T., Hirschberg, R., Kopple, J., Katz, L., Kurtin, P., Ashbrook, D., and Wolfson, M.: Efficacy of L-carnitine in hemodialysis: a multi-center controlled clinical trial. Kidney Int. 31:226 (1987).

    Google Scholar 

  35. Yderstraede, K.B., Pedersen, F.B., Dragsholt, C., Trostmann, A., Laier, E., and Larsen, H.F.: The effect of L-carnitine on lipid-metabolism in patients on chronic hemodialysis. Nephrol. Dial. Transplant 1:238 (1987).

    PubMed  CAS  Google Scholar 

  36. Böhles, H.J., and Akcetin, Z.: Ketogenic effects of low and high levels of carnitine during total parenteral nutrition in the rat. Am. J. Clin. Nutr. 46:47 (1987).

    PubMed  Google Scholar 

  37. Guarnieri, G., Toigo, G., Situlin, R., DelBianco, M.A., Corsi, M., LoGreco, P., Paviotti, G., Mioni, G., and Campanacci, L.: Carnitine metabolism in chronic renal failure. Kidney Int. 32 (suppl. 22):116 (1987).

    Google Scholar 

  38. Glöggler, A., Bulla, M., and Fürst, P.: The effect of low-dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children. Kidney Int. in press (1989).

    Google Scholar 

  39. D’Attellis, N.P., Kulapongse, S., Richelle, M., Dahlan, W., Elwyn, D.H., Rössle, C., Fürst, P., and Carpentier, Y.: Metabolic utilization of energy substrates during intravenous L-carnitine supplementation in normal man. Metabolism in press (1989).

    Google Scholar 

  40. Sandstedt, S., Cederblad, G. , Cennmarken, C., Lindholm, M., Larsson, J.: The effect of L-carnitine supplemented TPN on lipid- and nitrogen-metabolism in critically ill patients. Clin. Nutr. 6 (spec, suppl.):24 (1987).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this paper

Cite this paper

Fürst, P., Glöggler, A., Rössle, C. (1989). Carnitine Supplementation in Uremia. In: Hörl, W.H., Schollmeyer, P.J. (eds) New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis. Advances in Experimental Medicine and Biology, vol 260. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5718-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5718-6_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5720-9

  • Online ISBN: 978-1-4684-5718-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics